Trials / Conditions / Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
3 registered clinical trials studyying Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma NCT05618327 | Shanghai Junshi Bioscience Co., Ltd. | Phase 1 |
| Unknown | Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma NCT05322330 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Unknown | Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma NCT05312476 | The First Affiliated Hospital of Soochow University | Phase 2 |